Subscribe to our mailing list to receive 10% off your first order

Clinical Trials

# Title Year Dose
#
1
Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects
FOCUS AREA INSULIN
2023
250mg
#
2
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
FOCUS AREA ARTERIES
2023
250mg
#
3
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study
FOCUS AREA OBESITY
2023
2,000mg
#
4
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
FOCUS AREA SAFETY EFFICACY
2022
300mg
600mg
900mg
#
5
Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study
FOCUS AREA DIABETES
2022
250mg
#
6
Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals
FOCUS AREA BLOOD TRIGLYCERIDES
2022
300mg
#
7
Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women
FOCUS AREA SAFETY
2022
1,250mg
#
8
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
FOCUS AREA METABOLISM ARTERIES
2022
250mg
#
9
Clinical evaluation of changes in biomarkers by oral intake of NMN
FOCUS AREA BIOMARKERS EFFICACY
2022
300mg
#
10
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
FOCUS AREA MUSCLE FUNCTION MEN
2022
250mg
#
11
A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults
FOCUS AREA SAFETY EFFICACY
2022
300mg
#
12
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
FOCUS AREA INSULIN WOMEN
2022
250mg
#
13
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
FOCUS AREA SAFETY EFFICACY
2022
250mg
#
14
Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study
FOCUS AREA SLEEP QUALITY FATIGUE
2022
250mg
#
15
MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults
FOCUS AREA EFFICACY
2022
1,000mg
#
16
Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study
FOCUS AREA AEROBIC CAPACITY
2021
1,200mg
#
17
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men
FOCUS AREA EFFICACY
2020
500mg
# Title Year Dose
#
1
Resveratrol and Vascular Health: Evidence from Clinical Studies and Mechanisms of Actions
FOCUS AREA CARDIOVASCULAR
2024
Varies
#
2
Unraveling the Therapeutic Efficacy of Resveratrol in Alzheimer’s Disease: An Umbrella Review
FOCUS AREA ALZHEIMER'S
2023
Varies
#
3
Resveratrol for Inflammatory Bowel Disease in Preclinical Studies: A Systematic Review and Meta-Analysis
FOCUS AREA INFLAMMATORY BOWEL DISEASE
2023
Varies
#
4
The Therapeutic Potential of Resveratrol: A Review of Clinical Trials
FOCUS AREA CANCER
2023
Varies
#
5
Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
FOCUS AREA MULTIFACETED
2022
Varies
#
6
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Clinical Trials
FOCUS AREA MULTIFACETED
2022
Varies
#
7
The Role of Resveratrol in Neurogenesis: A Systematic Review
FOCUS AREA NEUROGENESIS
2022
Varies
#
8
Resveratrol in the Treatment of Diabetes Mellitus: A Review
FOCUS AREA DIABETES
2022
Varies
#
9
Exploring the Anti-Inflammatory Effects of Resveratrol in Chronic Diseases
FOCUS AREA ANTI-INFLAMMATORY
2021
Varies
#
10
Resveratrol as a Potential Therapeutic Agent for Neurodegenerative Diseases
FOCUS AREA NEURODEGENERATIVE DISEASES
2021
Varies
# Title Year Dose
#
1
Apigenin Protects Against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations
FOCUS AREA NEUROPROTECTION
2024
25mg/kg
#
2
Experimental Evidence for Anti-Metastatic Actions of Apigenin: A Mini Review
FOCUS AREA CANCER
2023
Varies
#
3
Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis
FOCUS AREA CANCER
2023
Varies
#
4
Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy
FOCUS AREA PHARMACOKINETICS
2023
Varies
#
5
The Beneficial Role of Apigenin Against Cognitive and Neurobehavioural Dysfunction: A Systematic Review
FOCUS AREA NEUROPROTECTION
2023
Varies
#
6
The Therapeutic Potential of Apigenin
FOCUS AREA MULTIFACETED
2023
Varies
#
7
Apigenin and Its Dermatological Applications: A Comprehensive Review
FOCUS AREA DERMATOLOGY
2022
Varies
#
8
Apigenin: A Natural Molecule at the Intersection of Sleep and Aging
FOCUS AREA SLEEP
2022
Varies
#
9
The Effects of Apigenin in the Treatment of Diabetic Nephropathy
FOCUS AREA DIABETIC NEPHROPATHY
2022
Varies
#
10
Exploring the Role of Apigenin in Neuroinflammation
FOCUS AREA NEUROINFLAMMATION
2021
Varies
# Title Year Dose
#
1
Efficacy and Safety of HIMABERB® Berberine on Glycemic Control in Patients with Prediabetes: A Double-Blind, Placebo-Controlled, Randomized Pilot Trial
FOCUS AREA INSULIN
2024
500mg
#
2
Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Systematic Review
FOCUS AREA LIVER DISEASE
2023
1000mg
#
3
Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
FOCUS AREA METABOLIC DISORDERS
2023
1500mg
#
4
Therapeutic Application of Berberine: A Consolidated Review
FOCUS AREA ANTICANCER
2023
500mg
#
5
Berberine in the Treatment of Diabetes Mellitus: A Review
FOCUS AREA DIABETES
2022
300mg
#
6
Clinical Evaluation of Berberine’s Effects on Obesity and Hyperlipidemia: A Double-Blind, Placebo-Controlled Study
FOCUS AREA OBESITY
2022
600mg
#
7
Berberine’s Impact on Cardiovascular Health: Preclinical and Clinical Trials Review
FOCUS AREA CARDIOVASCULAR
2022
1000mg
#
8
Safety and Efficacy of Berberine in Managing Blood Lipids: A Comprehensive Review
FOCUS AREA SAFETY
2022
300mg
#
9
Neuroprotective and Cognitive Benefits of Berberine: A Clinical Review
FOCUS AREA NEUROPROTECTION
2021
500mg
#
10
Berberine as an Anti-Inflammatory Agent in Chronic Diseases: Systematic Review
FOCUS AREA INFLAMMATION
2021
750mg
# Title Year Dose
#
1
Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth
FOCUS AREA NAD+ CELL GROWTH GLYCOLYSIS
2021
-
#
2
Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice
FOCUS AREA NAD+ METABOLISM
2021
-